Works matching IS 03618609 AND DT 2020 AND VI 95 AND IP 10

Results: 32
    1
    2

    Heparin induced thrombocytopenia antibodies in Covid‐19.

    Published in:
    American Journal of Hematology, 2020, v. 95, n. 10, p. E295, doi. 10.1002/ajh.25935
    By:
    • Patell, Rushad;
    • Khan, Adeel M;
    • Bogue, Thomas;
    • Merrill, Mwanasha;
    • Koshy, Anita;
    • Bindal, Poorva;
    • Joyce, Robin;
    • Aird, William C;
    • Neuberg, Donna;
    • Bauer, Kenneth A;
    • Zwicker, Jeffrey I
    Publication type:
    Article
    3

    Impact of total body irradiation‐ vs chemotherapy‐based myeloablative conditioning on outcomes of haploidentical hematopoietic cell transplantation for acute myelogenous leukemia.

    Published in:
    American Journal of Hematology, 2020, v. 95, n. 10, p. 1200, doi. 10.1002/ajh.25934
    By:
    • Dholaria, Bhagirathbhai;
    • Labopin, Myriam;
    • Angelucci, Emanuele;
    • Ciceri, Fabio;
    • Diez‐Martin, Jose L.;
    • Bruno, Benedetto;
    • Sica, Simona;
    • Koc, Yener;
    • Gülbas, Zafer;
    • Schmid, Christoph;
    • Blaise, Didier;
    • Carella, Angelo Michele;
    • Visani, Guiseppe;
    • Savani, Bipin N.;
    • Nagler, Arnon;
    • Mohty, Mohamad
    Publication type:
    Article
    4
    5
    6
    7

    Venetoclax and hypomethylating agents in FLT3‐mutated acute myeloid leukemia.

    Published in:
    American Journal of Hematology, 2020, v. 95, n. 10, p. 1193, doi. 10.1002/ajh.25929
    By:
    • Aldoss, Ibrahim;
    • Zhang, Jianying;
    • Mei, Matthew;
    • Al Malki, Monzr M;
    • Arslan, Shukaib;
    • Ngo, Dat;
    • Aribi, Ahmed;
    • Ali, Haris;
    • Sandhu, Karamjeet;
    • Salhotra, Amandeep;
    • Koller, Paul;
    • Khaled, Samer;
    • Artz, Andrew;
    • Snyder, David;
    • Nakamura, Ryotaro;
    • Forman, Stephen J;
    • Stein, Anthony S.;
    • Marcucci, Guido;
    • Pullarkat, Vinod
    Publication type:
    Article
    8
    9
    10
    11
    12

    Haploidentical transplants for patients with relapse after the first allograft.

    Published in:
    American Journal of Hematology, 2020, v. 95, n. 10, p. 1187, doi. 10.1002/ajh.25924
    By:
    • Srour, Samer A.;
    • Kongtim, Piyanuch;
    • Rondon, Gabriela;
    • Chen, Julianne;
    • Petropoulos, Demetrios;
    • Ramdial, Jeremy;
    • Popat, Uday;
    • Kebriaei, Partow;
    • Qazilbash, Muzaffar;
    • Shpall, Elizabeth J.;
    • Champlin, Richard E.;
    • Ciurea, Stefan O.
    Publication type:
    Article
    13
    14

    Characteristics of late transplant‐associated thrombotic microangiopathy in patients who underwent allogeneic hematopoietic stem cell transplantation.

    Published in:
    American Journal of Hematology, 2020, v. 95, n. 10, p. 1170, doi. 10.1002/ajh.25922
    By:
    • Heybeli, Cihan;
    • Sridharan, Meera;
    • Alkhateeb, Hassan B.;
    • Villasboas Bisneto, Jose C.;
    • Buadi, Francis K.;
    • Chen, Dong;
    • Dingli, David;
    • Dispenzieri, Angela;
    • Gertz, Morie A.;
    • Go, Ronald S.;
    • Hashmi, Shahrukh K.;
    • Hayman, Suzanne R.;
    • Hogan, William J.;
    • Inwards, David J.;
    • Kenderian, Saad S.;
    • Kumar, Shaji K.;
    • Litzow, Mark R.;
    • Porrata, Luis F.;
    • Lacy, Martha Q.;
    • Micallef, Ivana N.
    Publication type:
    Article
    15

    Characterization of the severe phenotype of pyruvate kinase deficiency.

    Published in:
    American Journal of Hematology, 2020, v. 95, n. 10, p. E281, doi. 10.1002/ajh.25926
    By:
    • Al‐Samkari, Hanny;
    • Beers, Eduard J.;
    • Morton, D. Holmes;
    • Barcellini, Wilma;
    • Eber, Stefan W.;
    • Glader, Bertil;
    • Yaish, Hassan M.;
    • Chonat, Satheesh;
    • Kuo, Kevin H. M.;
    • Kollmar, Nina;
    • Despotovic, Jenny M.;
    • Pospíšilová, Dagmar;
    • Knoll, Christine M.;
    • Kwiatkowski, Janet L.;
    • Pastore, Yves D.;
    • Thompson, Alexis A.;
    • Wlodarski, Marcin W.;
    • Ravindranath, Yaddanapudi;
    • Rothman, Jennifer A.;
    • Wang, Heng
    Publication type:
    Article
    16
    17

    Sensitive and broadly applicable residual disease detection in acute myeloid leukemia using flow cytometry‐based leukemic cell enrichment followed by mutational profiling.

    Published in:
    American Journal of Hematology, 2020, v. 95, n. 10, p. 1148, doi. 10.1002/ajh.25918
    By:
    • Daga, Shruti;
    • Rosenberger, Angelika;
    • Kashofer, Karl;
    • Heitzer, Ellen;
    • Quehenberger, Franz;
    • Halbwedl, Iris;
    • Graf, Ricarda;
    • Krisper, Nina;
    • Prietl, Barbara;
    • Höfler, Gerald;
    • Reinisch, Andreas;
    • Zebisch, Armin;
    • Sill, Heinz;
    • Wölfler, Albert
    Publication type:
    Article
    18

    Haploidentical transplants for patients with graft failure after the first allograft.

    Published in:
    American Journal of Hematology, 2020, v. 95, n. 10, p. E267, doi. 10.1002/ajh.25917
    By:
    • Kongtim, Piyanuch;
    • Bittencourt, Maria;
    • Srour, Samer A.;
    • Ramdial, Jeremy;
    • Rondon, Gabriela;
    • Chen, Julianne;
    • Khouri, Issa;
    • Betul, Oran;
    • Popat, Uday;
    • Olson, Amanda;
    • Bashir, Qaiser;
    • Shpall, Elizabeth J.;
    • Kebriaei, Partow;
    • Champlin, Richard E.;
    • Ciurea, Stefan O.
    Publication type:
    Article
    19
    20

    Localized immunoglobulin light chain amyloidosis: Novel insights including prognostic factors for local progression.

    Published in:
    American Journal of Hematology, 2020, v. 95, n. 10, p. 1158, doi. 10.1002/ajh.25915
    By:
    • Basset, Marco;
    • Hummedah, Kamal;
    • Kimmich, Christoph;
    • Veelken, Kaya;
    • Dittrich, Tobias;
    • Brandelik, Simone;
    • Kreuter, Michael;
    • Hassel, Jessica;
    • Bosch, Nikolaus;
    • Stuhlmann‐Laeisz, Christiane;
    • Blank, Norbert;
    • Müller‐Tidow, Carsten;
    • Röcken, Christoph;
    • Hegenbart, Ute;
    • Schönland, Stefan
    Publication type:
    Article
    21
    22
    23
    24
    25
    26
    27

    Genetic lesions disrupting calreticulin 3′‐untranslated region in JAK2 mutation‐negative polycythemia vera.

    Published in:
    American Journal of Hematology, 2020, v. 95, n. 10, p. E263, doi. 10.1002/ajh.25911
    By:
    • Quattrocchi, Alberto;
    • Maiorca, Carlo;
    • Billi, Monia;
    • Tomassini, Simona;
    • De Marinis, Elisabetta;
    • Cenfra, Natalia;
    • Equitani, Francesco;
    • Gentile, Martina;
    • Ceccherelli, Alessia;
    • Banella, Cristina;
    • Mecarocci, Sergio;
    • Scerpa, Maria Cristina;
    • Pisanò, Stefania;
    • Pacilli, Annalisa;
    • Di Cristofano, Claudio;
    • Mancini, Massimiliano;
    • Guglielmelli, Paola;
    • Vannucchi, Alessandro Maria;
    • Noguera, Nelida;
    • Grignani, Francesco
    Publication type:
    Article
    28
    29

    Low‐dose ponatinib is a good option in chronic myeloid leukemia patients intolerant to previous TKIs.

    Published in:
    American Journal of Hematology, 2020, v. 95, n. 10, p. E260, doi. 10.1002/ajh.25908
    By:
    • Iurlo, Alessandra;
    • Cattaneo, Daniele;
    • Malato, Alessandra;
    • Accurso, Vincenzo;
    • Annunziata, Mario;
    • Gozzini, Antonella;
    • Scortechini, Anna Rita;
    • Bucelli, Cristina;
    • Scalzulli, Emilia;
    • Attolico, Imma;
    • Maggi, Alessandro;
    • Martino, Bruno;
    • Caocci, Giovanni;
    • Abruzzese, Elisabetta;
    • Pregno, Patrizia;
    • Luciano, Luigiana;
    • Breccia, Massimo
    Publication type:
    Article
    30

    The clinical impact of time to response in de novo accelerated‐phase chronic myeloid leukemia.

    Published in:
    American Journal of Hematology, 2020, v. 95, n. 10, p. 1127, doi. 10.1002/ajh.25907
    By:
    • Ohanian, Maro;
    • Kantarjian, Hagop M.;
    • Shoukier, Mahran;
    • Dellasala, Sara;
    • Musaelyan, Arine;
    • Nogueras Gonzalez, Graciela M.;
    • Jabbour, Elias;
    • Abruzzo, Lynne;
    • Verstovsek, Srdan;
    • Borthakur, Gautam;
    • Ravandi, Farhad;
    • Garcia‐Manero, Guillermo;
    • Tamamyan, Gevorg;
    • Champlin, Richard;
    • Pierce, Sherry;
    • Ferrajoli, Alessandra;
    • Kadia, Tapan;
    • Cortes, Jorge E.
    Publication type:
    Article
    31
    32

    Cytogenetic risk score maintains its prognostic significance in AML patients with detectable measurable residual disease undergoing transplantation in remission: On behalf of the acute leukemia working party of the European society for blood and marrow transplantation

    Published in:
    American Journal of Hematology, 2020, v. 95, n. 10, p. 1135, doi. 10.1002/ajh.25905
    By:
    • Nagler, Arnon;
    • Labopin, Myriam;
    • Canaani, Jonathan;
    • Niittyvuopio, Riitta;
    • Socié, Gerard;
    • Kröger, Nicolaus;
    • Itäla‐Remes, Maija;
    • Yakoub‐Agha, Ibrahim;
    • Labussière‐Wallet, Hélène;
    • Gallego‐Hernanz, Maria P.;
    • Deconinck, Eric;
    • Chevallier, Patrice;
    • Finke, Jürgen;
    • Esteve, Jordi;
    • Mohty, Mohamad
    Publication type:
    Article